Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298857 · ClinicalTrials.gov registry record · Phase 4
A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights
A Phase 4 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT00298857 is a Phase 4 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 22 participants.
The verdict
NCT00298857, a Phase 4 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the blood levels of valproic acid in subjects with different body weights and to evaluate whether the pharmacokinetic parameters of this drug is altered in the obese population.
Interventions
- DRUG Valproic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00298857
The ClinicalTrials.gov registry entry for NCT00298857 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valproic acid is the first listed.
NCT00298857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00298857 about?
NCT00298857 is a clinical study titled "A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights". The purpose of this study is to compare the blood levels of valproic acid in subjects with different body weights and to evaluate whether the pharmacokinetic parameters of this drug is altered in the obese population.
What is the current status of trial NCT00298857?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2006-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00298857?
The interventions under investigation include: Valproic acid (DRUG).
Who is sponsoring clinical trial NCT00298857?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.